Laparoscopic US-guided radiofrequency ablation of unresectable hepatocellular carcinoma in liver cirrhosis: feasibility and clinical outcome.

@article{Casaccia2008LaparoscopicUR,
  title={Laparoscopic US-guided radiofrequency ablation of unresectable hepatocellular carcinoma in liver cirrhosis: feasibility and clinical outcome.},
  author={M. Casaccia and Enzo Andorno and Ilaria Nardi and Bianca Maria Troilo and Gabriele Barabino and Gregorio Santori and U. Valente},
  journal={Journal of laparoendoscopic & advanced surgical techniques. Part A},
  year={2008},
  volume={18 6},
  pages={797-801}
}
BACKGROUND Radiofrequency ablation (RFA) is a safe, effective treatment in patients with unresectable primary liver malignancies. The laparoscopic approach to RFA (LRFA) has proved to be superior to the percutaneous approach in lesions that are difficult or impossible to be treated in such a way or in severe liver disease. Recent advances in laparoscopic ultrasound (LUS) have greatly improved the accuracy in detecting intrahepatic hepatocellular carcinoma (HCC) nodules, many of which were… CONTINUE READING
9 Citations
24 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Resection of liver tumors: Special emphasis on neoadjuvant and adjuvant therapy

  • M Selzner, PA Clavien
  • Malignant Liver Tumors : Current and Emerging…
  • 1999
Highly Influential
4 Excerpts

Kuoch V , et al . Adverse events during radiofrequency treatment of 582 hepatic tumors

  • T deBaere, P Risse
  • Am J Roentgenol
  • 2003

Similar Papers

Loading similar papers…